Arcutis Biotherapeutics's total assets for Q1 2026 were $460.00M, an increase of 6.24% from the previous quarter. ARQT total liabilities were $270.36M for the fiscal quarter, a 11.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.